Clinical Trials in Houston

Showing 7461-7480 of 17,885 trials

Pixantrone (BBR 2778) in Patients With Refractory Acute Myelogenous Leukemia (AML)

NCT00106600

The goal of this study is to find the safest dose of Pixantrone (BBR 2778) that can be given to patients with Acute Myelogenous Leukemia (AML). After the safest dose is found, up to an additional 86 patients will be enrolled. During this part of the study, the safety and effectiveness will be evaluated.

Acute Myelogenous Leukemia

CTI BioPharma12 participantsStarted Mar 2005

Houston, Texas, United States

TERMINATEDPhase 1< 1 mile

A Study of BTX-1188 in Subjects With Advanced Malignancies

NCT05144334

This is a multicenter, open label, nonrandomized, sequential dose escalation, multiple dose study designed to evaluate the safety, toxicity, and pharmacokinetics (PK) as well as preliminary efficacy of BTX-1188 orally administered in subjects with advanced malignancies.

Advanced Solid TumorNon Hodgkin LymphomaAcute Myeloid Leukemia

Biotheryx, Inc.8 participantsStarted Jan 2022

Duarte, California, United States • New York, New York, United States • Cincinnati, Ohio, United States +1 more locations

COMPLETEDPhase 3< 1 mile

Evaluating the Effects of Tasimelteon vs. Placebo on Jet Lag Type Insomnia

NCT03373201

The aim of this study is to investigate tasimelteon vs. placebo on sleep in healthy individuals after a phase advance in jet lag type insomnia.

Jet Lag Type Insomnia

Vanda Pharmaceuticals320 participantsStarted Oct 2017

Little Rock, Arkansas, United States • Alameda, California, United States • San Diego, California, United States +9 more locations

Pixantrone (BBR 2778) in Patients With Refractory Acute Myelogenous Leukemia (AML)

A Study of BTX-1188 in Subjects With Advanced Malignancies

Evaluating the Effects of Tasimelteon vs. Placebo on Jet Lag Type Insomnia

Find Trials by Condition in Houston

INCAGN01876 in Combination With Immunotherapy in Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Study of Cytoreductive Surgery and Hyperthermic Intrathoracic Pleural Chemotherapy (HITC) With Escalating Doses for Children and Adolescents With Unilateral Pleural Malignancy

Alternate Day Versus Daily Oral Iron Therapy in Adolescents

39946-I Laser and Bevacizumab Treatment for Retinopathy of Prematurity

A Study of a Personalized Cancer Vaccine Targeting Shared Neoantigens

Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency

PCI Treatment/Gemcitabine & Chemotherapy vs Chemotherapy Alone in Patients With Inoperable Extrahepatic Bile Duct Cancer

Safety and Tolerability Study of Suprachoroidal Injection of CLS-AX Following Anti-VEGF Therapy in Neovascular AMD

Oral CF101 and Methotrexate Treatment in Rheumatoid Arthritis Patients

Addressing Dementia Via Agitation-Centered Evaluation

Study of Sotatercept for the Treatment of Chemotherapy Induced Anemia in Patients With Metastatic Breast Cancer (MK-7962-012)

Safety & Efficacy of Pilocarpine Ophthalmic Spray for Temporary Improvement of Near Vision in Presbyopic Adults

Safety, Tolerability and Efficacy Study of V117957 in Subjects With Insomnia Associated With Alcohol Cessation

An add-on Study to the FIGARO-DKD Study Called FIGARO-BM to Learn About the Link Between Biomarkers (Substances in the Blood Used as Indicators of Biological Processes, Disease Processes or Responses to Medication) and Finerenone in FIGARO-DKD Participants

Human Epilepsy Project 2: Resistant Focal Seizures Study

Study of Ipatasertib or Apitolisib With Abiraterone Acetate Versus Abiraterone Acetate in Participants With Castration-Resistant Prostate Cancer Previously Treated With Docetaxel Chemotherapy

Multi-Center Pilot Study of truSculpt Device